|Year : 2020 | Volume
| Issue : 3 | Page : 28-33
Metal - based Nanoparticle Siddha Formulations for the Management of Emerging Infectious Diseases (EIDs)
K Samraj1, K Nandhagopal1, S Thillaivanan2, A Silambarasan3
1 Siddha Clinical Research Unit, (CCRS, Ministry of AYUSH, Govt. of India), Tirupati, Andhra Pradesh - 517 507, India
2 Govt. of Tamil Nadu, Gudiyattam, Tamil Nadu, India
3 Velumailu Siddha Medical College, Sriperumpudur, Kancheepuram - 602 105, Tamil Nadu, India
|Date of Web Publication||27-Sep-2021|
Siddha Clinical Research Unit, (CCRS, Ministry of AYUSH, Govt. of India), Tirupati, Andhra Pradesh - 517 507
Source of Support: None, Conflict of Interest: None
Background: Emerging Infectious Diseases (EIDs) are infections are rapidly increasing in incidence or geographic range; includes previously unrecognized diseases such as AIDS, severe acute respiratory syndrome (SARS), ebola-haemorrhagic fever, nipah virus encephalitis, dengue fever and recent COVID-19 pandemic. Most pathogens involved in EID events are drug-resistant bacteria (54.3%), but virus constitute only 25.4% of EID events, in contrast to previous analyses which suggest that 37–44% of emerging pathogens are viruses and 10–30% bacteria. Metal-based nanoparticles accounts for their considerable interaction with bio molecules within the cell and on the cell surface. These unique properties make metal nanoparticles potential therapeutics for the treatment of infectious diseases Method: In Siddha system of medicine, Ulogankal (metals) are eleven in numbers; they are Thangam (gold), Velli (silver), Sembu (copper), Naagam (zinc), Ehgu (steel), Irumbu (iron), Pithalai (brass), Thara (alloy of copper and lead), Karuvangam (lead) and Velvangam (tin). This review focuses about the antimicrobial, anti-viral, anti-bacterial and immunomodulatory activities of metal-based nanoparticles (NPs) which were already quoted in the Siddha system of medicine. Result: Metal nanoparticles have sufficient physico-chemical properties and surface charges. This review revealed that the metal-based medicines have considerable potential to manage and to provide prophylactic support to the EIDs due to immune enhancing, anti-viral, antibacterial, anti-microbial properties. Conclusion: Nanoparticles utilization is “double-edged sword” providing positive advantages for usefulness and negative impacts on health upon exposure. So, the manufacture authentications, Specific guidelines for metal drugs handling for clinical practice, Novel Drug Delivery System (NDDS), research rationales are essential for the metal based Siddha Medicines (Parpam, Chenduram and Chunnam) in this infection emerging period.
Keywords: COVID-19, Infectious Diseases, Nano, Ulogam Particles.
|How to cite this article:|
Samraj K, Nandhagopal K, Thillaivanan S, Silambarasan A. Metal - based Nanoparticle Siddha Formulations for the Management of Emerging Infectious Diseases (EIDs). J Res Siddha Med 2020;3, Suppl S1:28-33
|How to cite this URL:|
Samraj K, Nandhagopal K, Thillaivanan S, Silambarasan A. Metal - based Nanoparticle Siddha Formulations for the Management of Emerging Infectious Diseases (EIDs). J Res Siddha Med [serial online] 2020 [cited 2021 Dec 3];3, Suppl S1:28-33. Available from: http://www.jrsm.com/text.asp?2020/3/3/28/326808
| Introduction|| |
Emerging infectious diseases (EIDs) are infections that are rapidly increasing in incidence or geographic range, including such previously unrecognized diseases like AIDS, severe acute respiratory syndrome (SARS), ebola-haemorrhagic fever and nipah virus encephalitis, dengue fever and recent COVID-19 pandemic. EIDs are significant burden on socio-economic, environmental and eco-logical factors. Infectious diseases account for 29 out of the 96 major causes of human morbidity and mortality listed by the World Health Organization. And also, emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide. The Centres for Disease Control and Prevention conservatively estimates that at least 23,000 people die annually in the United States as a result of an infection with an antibiotic-resistant organism. Most pathogens involved in EID events are drug-resistant bacteria (54.3%). Virus constitute only 25.4% of EID events, in contrast to previous analyses which suggest that 37–44% of emerging pathogens are viruses and 10–30% are bacteria,.
Currently, the emergence of this COVID-19 has posed a situation that warrants urgent global attention. Though drugs are available in mainstream medicine for treating symptoms of COVID-19, currently there are no preventive medicine and exact treatment options. In view of this, complementary and alternative medicine (CAM) offers a plethora of interesting preventive possibilities in patients.
Siddha system of medicine is one of the oldest traditional systems of medicine, which has been originated from India and is practiced mostly in the southern part of this country for treating various diseases including even chronic conditions. Pharmacopoeia of Siddha comprises of drugs derived not only from herbs but also from minerals, metals and animal products. Preparing medicines from metals and minerals is one of the unique features of Siddha system of medicine. These medicines were prepared in the form of Parpam, Chendooram, Chunnam, Kattu, Kalangu etc. This review article explore about the metallic nano particles (NPs) present in Siddha System of Medicine. Metal-based nanoparticles accounts for their considerable interaction with bio molecules within the cell and on the cell surface. Their high surface area promotes cell permeability. Metal nanoparticles have significant physico-chemical properties and surface charges. These unique properties make metal nanoparticles potential therapeutics for the treatment of infectious diseases. And, using metal nanoparticles as prevention and management can induce more efficient immune responses against microbial infection. This short review will be focused on Siddha metal-based medicines as potential therapeutics against infectious diseases.
| Methodology|| |
Siddha system utilized the following metals in the form of nanoparticles for various kinds of diseases from the ancient period. In Siddha, Ulogankal (metals) are eleven in numbers, they are Thangam (gold), Velli (silver), Sembu (copper), Naagam (zinc), Ehgu (steel), Irumbu (iron), Pithalai (brass), Thara (alloy of copper and lead), Karuvangam (lead) and Velvangam (tin). All the metals are prepared as a Parpam, Chenduram, Chunnam format for using medicines,. A nanoparticle property is based on its size, charge, hydrophobicity, hydrophilicity, and the steric effects. This review focuses about the anti-microbial, anti-viral, anti-bacterial and immunomodulatory activities of metal-based nanoparticles (NPs) which were already quoted in the Siddha system of medicine for the management of EIDs in pandemic situations.
| Results|| |
Metal nanoparticles have sufficient physico-chemical properties and surface charges. It revealed that the Velli (Silver NP), Thangam (Gold NP), Velvangam (TIN NP), Ayam (Iron NP), Nagam (Zinc NP) metal-based medicines have considerable potential to manage and to provide prophylactic support to the EIDs due to immune enhancing, anti-viral, antibacterial, anti-microbial properties [Table 1].
| Discussion|| |
Siddha medicines have many formulations with the combination of metals and minerals because of its minimal quantity to avail the high potency results. Saint Thirumoolar’s hypothesis about atomic theory has been reinstated as nanotechnology in this decade. Hence, Parpam, Chenduram and Chunnam of silver, gold, tin, iron, copper and zinc act as a Novel Drug Delivery System (NDDS) and capable to produce better result on microorganisms with least side effects. By approaching in NDDS may increase the therapeutic value, bioavailability and act as smart drug. Since most of Siddha nano particle drug has been absorbed in the mucosal level. Nano particles improves the efficacy of drug delivery to the cells in cytoplasm and its absorption because of their size.
Nanoparticles (NPs) exhibit antibacterial activity resulting from their ability to produce reactive oxygen species that damage the bacteria and their ability to bind to DNA or RNA, thereby hindering microbial replication processes,.
Metal-based NPs have been found to be effective against virus, resulting in decreased viral growth and replication. NPs interact with the CD4 membrane resulting in endocytosis. And the pH-dependent endosomal escape of the nanoparticles into the cell cytoplasm resulted in inhibition of viral protease.
The metal nanoparticles provoke inflammatory cytokines and increase dendritic cell maturation, expression of co-stimulatory molecules and activation - proliferation of prime immature T-cell. CD trapped inside fullerene cage nanoparticles has specific immunomodulatory effects on T-cells and macrophages, including polarization of the cytokine48.
Metal based Siddha formulations can be stored for a long period compared to the herbal based medicine. At the time of pandemic, large quantity of medicines is required to control the circumstances. If, we start using the metal-based medicine on pandemic time, the quantity of the medicine also would not fall short.
| Conclusion|| |
Nanotechnology in medicine is one of the most exciting industrial innovations of the 21st century. Many metal-based nanoparticles, such as nano-silver, nano-metallic oxides (zinc oxide, titanium dioxide, iron oxide and quantum dots) are applied for many therapeutic uses. This review revealed that the metal-based medicines are considerably potent to manage and prophylactically support during EIDs with immune enhancing, anti-viral, anti-bacterial and anti-microbial properties. Nanoparticles utilization is “double-edged sword” providing positive advantages for usefulness and negative impacts on health upon exposure. This prudence was handled by in long centuries ago. So, the manufacture authentications, Specific guidelines for metal drugs handling for clinical practice, Novel Drug Delivery System (NDDS), research rationales are essential for the metal based Siddha Medicines (Parpam, Chenduram and Chunnam) in this infection emerging period.
| References|| |
Relman DA, Hamburg MA, Eileen R, Mack A. Microbial Evolution and Co-Adaptation. Microbial Evolution and Co-Adaptation 2009;1-17.
. World Health Organization: c2020 [cited 2020 November 20]. Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature 2008;451(7181):990–3.
Taylor LH, Latham SM, Woolhouse MEJ. Risk factors for human disease emergence. Philos Trans R Soc B Biol Sci 2001;356(1411):983–9.
Hoffman SB. Mechanisms of Antibiotic Resistance. Compend Contin Educ Pract Vet 2001;23(5):464–72.
Cleaveland S, Laurenson MK, Taylor LH. Diseases of humans and their domestic mammals: Pathogen characteristics, host range and the risk of emergence. Philos Trans R Soc B Biol Sci 2001;356(1411):991–9.
Arora R, Chawla R, Marwah R, Arora P, Sharma RK, Kaushik V, et al. Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud 2011;2011.
Ram A, Arul Joseph D, Balachandar S, Pal Singh V. Medicinal plants from Siddha system of medicine useful for treating respiratory diseases. Int J Pharm Anal 2009;1(2):975–3079.
Mody V V, Siwale R, Singh A, Mody HR. Introduction to metallic nanoparticles 2010;2(4):282–9.
For S, Materia G, Speciality P. Central Council Of Indian Medicine 2016;1–33.
Shailaja R, Sugunthan S. Concept of nanotechnology in siddha medical literature. World J Pharm Res 2016;5(10):276-84.
Choi O, Deng KK, Kim NJ, Ross L, Surampalli RY, Hu Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 2008;42(12):3066–74.
Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology 2005;3:1–10.
Sun RWY, Chen R, Chung NPY, Ho CM, Lin CLS, Che CM. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun 2005;(40):5059–61.
Hu RL, Li SR, Kong FJ, Hou RJ, Guan XL, Guo F Inhibition effect of silver nanoparticles on herpes simplex virus 2. Genet Mol Res 2014;13(3):7022–8.
Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules 2011;16(10):8894–918.
Mori Y, Ono T, Miyahira Y, Nguyen VQ, Matsui T, Ishihara M. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett 2013;8(1):93.
Dong-xi Xiang, Qian Chen, Lin Pang, Cong-long Zheng. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro
. J Virol Methods 2011;178(1-2):137-42.
Lappas CM. The immunomodulatory effects of titanium dioxide and silver nanoparticles. Food Chem Toxicol 2015;85:78–83.
Krishnaraj C, Jagan EG, Rajasekar S, Selvakumar P, Kalaichelvan PT, Mohan N. Synthesis of silver nanoparticles using Acalypha indica
leaf extracts and its antibacterial activity against water borne pathogens. Colloids Surfaces B Biointerfaces 2010;76(1):50–6.
Tippayawat P, Phromviyo N, Boueroy P, Chompoosor A. Green synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activity. PeerJ 2016;2016(10):1–15.
Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surfaces B Biointerfaces 2003;28(4):313–8.
Verma A, Mehata MS. Controllable synthesis of silver nanoparticles using Neem leaves and their antimicrobial activity. J Radiat Res Appl Sci 2016;9(1):109–15.
Res JMB, Kesarkar R, Oza G, Pandey S, Dahake R, Mukherjee S, et al. Gold Nanoparticles: Effective as both inhibitors & virus neutralizing agents against HIV. Scholars Research Library 2012;2(2):276–83.
Baram-Pinto D, Shukla S, Gedanken A, Sarid R. Inhibition of HSV-1 attachment, entry and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small 2010;6(9):1044–50.
Chiodo F, Marradi M, Calvo J, Yuste E, Penadés S. Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs. Beilstein J Org Chem 2014;10:1339–46.
Hendrix Sloane, Misuraca, & Moore A.NIH Public Access. Bone 2013;23(1):1–7.
Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF, et al. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano 2014;8(10):10682–6.
Fatima, Far1. Fatima F, Bajpai P, Pathak N, Singh S, Priya S VSA and immunomodulatory efficacy of extracellularly synthesized silver and gold nanoparticles by a novel phosphate solubilizing fungus B tetramera
Trigilio J, Antoine TE, Paulowicz I, Mishra YK, Adelung R, Shukla D. Tin Oxide Nanowires Suppress Herpes Simplex Virus-1 Entry and Cell-to-Cell Membrane Fusion. PLoS One 2012;7(10):1–9.
Vonka V, Kanaka J, Hirsch I, Závadová H, Krčmář M, Suchánková A, et al. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus II. Herpes simplex type-2 antibody presence in sera taken at enrolment. Int J Cancer 1984;33(1):61–6.
Arokiyaraj S, Saravanan M, Udaya Prakash NK, Valan Arasu M, Vijayakumar B, Vincent S. Enhanced antibacterial activity of iron oxide magnetic nanoparticles treated with Argemone mexicana
L. leaf extract: An in vitro
study. Mater Res Bull 2013;48(9):3323–7.
Prabhu YT, Rao KV, Kumari BS, Kumar VSS, Pavani T. Synthesis of Fe3O4 nanoparticles and its antibacterial application. Int Nano Lett 2015;5(2):85–92.
Mahdavi M, Namvar F, Ahmad M Bin, Mohamad R. Green biosynthesis and characterization of magnetic iron oxide (Fe3O4) nanoparticles using seaweed (Sargassum muticum)
aqueous extract. Molecules 2013;18(5):5954–64.
Rafi MM, Ahmed KSZ, Nazeer KP, Siva Kumar D, Thamilselvan M. Synthesis, characterization and magnetic properties of hematite (a-Fe2O3) nanoparticles on polysaccharide templates and their antibacterial activity. Appl Nanosci 2015;5(4):515–20.
Mahmoodi S, Elmi A, Hallaj Nezhadi S. Copper Nanoparticles as Antibacterial Agents. J Mol Pharm Org Process Res 2018;06(01):1–7.
Raffi M, Mehrwan S, Bhatti TM, Akhter JI, Hameed A, Yawar W, et al. Investigations into the antibacterial behavior of copper nanoparticles against Escherichia coli
. Ann Microbiol 2010;60(1):75–80.
Azam A, Ahmed AS, Oves M, Khan MS, Memic A. Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains. Int J Nanomedicine 2012;7:3527–35.
Shionoiri N, Sato T, Fujimori Y, Nakayama T, Nemoto M, Matsunaga T, et al. Investigation of the antiviral properties of copper iodide nanoparticles against feline calicivirus. J Biosci Bioeng 2012;113(5):580–6.
Gunalan S, Sivaraj R, Rajendran V. Green synthesized ZnO nanoparticles against bacterial and fungal pathogens. Prog Nat Sci Mater Int 2012;22(6):693–700.
Saptarshi SR, Feltis BN, Wright PFA, Lopata AL. Investigating the immunomodulatory nature of zinc oxide nanoparticles at sub-cytotoxic levels in vitro
and after intranasal instillation in vivo
. J Nanobiotechnology 2015;13(1):1–11.
Reddy LS, Nisha MM, Joice M, Shilpa PN. Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae
. Pharm Biol 2014;52(11):1388–97.
Ansari SH, Islam F, Sameem M. Influence of nanotechnology on herbal drugs. J Adv Pharm Technol Res 2012;3(3):142–6.
Zain NM, Stapley AGF, Shama G. Green synthesis of silver and copper nanoparticles using ascorbic acid and chitosan for antimicrobial applications. Carbohydr Polym 2014;112:195–202.
Sheean et al. 2013 NIH Public Access. Bone 2008;23(1):1–7.
Aderibigbe BA. Metal-based nanoparticles for the treatment of infectious diseases. Molecules 2017;22(8):1370.
Luo YH, Chang LW, Lin P. Metal-Based Nanoparticles and the Immune System: Activation, Inflammation and Potential Applications. Biomed Res Int. 2015.